| Literature DB >> 25302013 |
Kazuki Matsuura1, Takafumi Mori2, Takeshi Miyamoto3, Chikako Suto4, Yusuke Saeki5, Shigeto Tanaka6, Hajime Kawamura7, Shinji Ohkubo8, Masaki Tanito9, Yoshitsugu Inoue10.
Abstract
PURPOSE: To elucidate Japanese trends for perioperative disinfection and antibiotic selection during cataract surgeries.Entities:
Keywords: antibiotic prophylaxis; cataract surgery; endophthalmitis; intracameral antibiotic; intraoperative iodine
Year: 2014 PMID: 25302013 PMCID: PMC4189719 DOI: 10.2147/OPTH.S64756
Source DB: PubMed Journal: Clin Ophthalmol ISSN: 1177-5467
Figure 1Survey regions.
Note: Eight regions (9 prefectures) were involved in the study, avoiding an uneven sampling distribution.
Distribution of respondents by annual cataract volume
| Volume (cases) | Respondents (n) |
|---|---|
| <100 | 75 |
| 100–300 | 160 |
| 300–500 | 69 |
| >500 | 82 |
Perioperative disinfection method
| 2014 | 2012 | |
|---|---|---|
| Periocular iodine compounds | 94% | ND |
| Conjunctival iodine compounds | 87% | ND |
| Ozonated solution | 3% | ND |
| Iodine compounds: several times | 14% | ND |
| Iodine compounds: repeated application | 7% | ND |
Abbreviation: ND, no data.
Concentration of preoperative iodine compounds
| Periocular skin PI (231) | Eye wash with PI (115) | Eye wash with PAI |
|---|---|---|
| 10% or 5%: 83% (191) | 10% or 5%: 3% (4) | 0.25% to 0.5%: 78% (118) |
| 0.625% to 2.5%: 17% (40) | 0.625% to 2.5%: 74% (85) | <0.25%: 22% (33) |
Note:
4-fold diluted PAI is equivalent to 0.5% PI.
Abbreviations: PI, povidone–iodine; PAI, polyvinyl alchol–iodine.
Perioperative and postoperative use of antibiotic prophylaxis
| 2014 (386) | 2012 (368) | |
|---|---|---|
| Preoperative topical antibiotics | 99% (382) | 99% (365) |
| Perioperative topical antibiotics | 35% (137) | 42% (155) |
| Postoperative topical antibiotics | 100% (386) | 100% (368) |
| Irrigation bottle | 22% (85) | 20% (72) |
| Intracameral injection | 7% (28) | 1% (4) |
| Subconjunctival injection | 23% (89) | 22% (82) |
| Antibiotic ointment | 79% (304) | 86% (318) |
Note: 2012 includes the data from both present study and previous study (n=16).
Initiation of preoperative topical antibiotics
| 2014 (380) | 2012 (361) | |
|---|---|---|
| Upon arrival or 1 day before surgery | 7% (26) | 12% (43) |
| 2–5 days before surgery | 83% (317) | 81% (292) |
| 1 week before surgery | 10% (37) | 7% (26) |
Note: 2012 includes the data from both present study and previous study (n=16).
Choice of antibiotics
| Preoperative topical antibiotics | Subconjunctival injection | Intracameral injection | Irrigation bottle | Antibiotic ointment | |
|---|---|---|---|---|---|
| Fluoroquinolone | 356 | 6 | 28 | 271 (ofloxacin) | |
| Cephem | 12+27 | 17 | 37 | ||
| Aminoglycoside | 1 | 63 | 6 | 2 | |
| Imipenem | 1 | 35 | |||
| Erythromycin | 1 | 25 | |||
| Penicillin | 1 | 3 | |||
| Others | 1 | 2 (vancomycin) | |||
| Used but not identified | 12 | 2 | 6 | ||
| Total | 382 | 89 | 28 | 85 | 304 |
Note:
27 surgeons used cephem combined with fluoroquinolone.
Duration of postoperative topical antibiotic use
| 2014 (386) | 2012 (368) | |
|---|---|---|
| <2 wk | 6% (25) | 5% (18) |
| 2–4 wk | 30% (117) | 28% (102) |
| 1–2 mth | 41% (160) | 41% (152) |
| >2 mth | 22% (84) | 26% (96) |
Note: 2012 includes the data from both present study and previous study (16).
Abbreviations: wk, week; mth, month.
Bacteria which cause endophthalmitis in Japan
| Bacteria (moxifloxacin: MIC90: μg/mL) | Onset: 0–29 days (cases) | Onset: after 1 month (cases) |
|---|---|---|
| 0 | 13 | |
| 28 | 4 | |
| 18 | 0 | |
| 22 | 0 | |
| 6 | 1 | |
| 4 | 0 | |
| Others | 26 | 12 |
| 104 | 30 |
Notes: The numbers shown in parenthesis are MIC90 in each bacteria to moxifloxacin. S. epidermidis involves some cases of CNS. S. aureus contains 16 cases of MRSA. Copyright © 2003. Translated and adapted from Medical-Aoi Publications, Inc. Hara J. Relation between causative organism and inflamation in pseudophakic endophthalmitis following cataract surgery. Journal of the Eye. 2003;(20):657–660.21
Abbreviations: MIC90, minimum inhibitory concentration, 90%; CNS, coagulase negative Staphylococcus; MRSA, methicillin-resistant Staphylococcus aureus.